CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-3467, a Polθ ATPase Inhibitor
SEOUL, South Korea--(BUSINESS WIRE)-- #BLA--FDA approves the biologics license application (BLA) that Dong-A submitted in 2023 for Imuldosa, a biosimilar referencing Stelara.
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS® in Treating Lupus Nephritis at ASN Kidney Week 2024
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today celebrates the recent Nobel Prize in Chemistry awarded to David Baker of the University of Washington, Seattle, WA, USA, "for computational protein design," and jointly to Demis Hassabis and John M. Jumper of Google DeepMind, London, UK, "for protein structure prediction." This accolade highlights the vital role of
MONTRÉAL--(BUSINESS WIRE)-- #Altasciences--Altasciences is proud to announce that Dr. Beatrice Setnik, PhD, has been honored as a PharmaVoice 100 winner. Dr. Setnik made the list of 100 honorees for her hands-on leadership and nearly 20 years of experience in clinical drug development, with a focus on abuse potential studies. In addition to her role as Chief Scientific Officer (CSO) at Altasciences, she serves as an adjunct professor at the University of Toronto and helps develop educational programs for child
OTTAWA, Ontario--(BUSINESS WIRE)--BIOTECanada, the national industry association representing the biotechnology ecosystem in Canada, is pleased to announce three new members joining the Board of Directors: Anne Woods, (Managing Director, Life Sciences, Banking at RBCx); Tamer Mohamed, (Founder & CEO at Aspect Biosystems); and Karen Heim, (Vice President and General Manager, Canada at Alexion Pharmaceuticals). These industry leaders bring a wealth of knowledge, experience, and leadership to
BURLINGTON, Mass.--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has opened its new €290 million biosafety testing facility in Rockville, Maryland, USA. Biosafety testing and analytical development are fundamental components of drug development and commercialization for traditional and novel modalities. Global demand for these services is growing at a double-digit rate1. “This expansion is the largest investment in contract testing
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter 2024 financial results on Wednesday, October 30, 2024. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the star
QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announces that its Board of Directors has approved the grant of options to purchase Shares (the “Options”) at an exercise price of $0.16 for a period of 10 years from the date of grant. An aggregate of 3,298,611 Options was granted to officers
VANCOUVER, British Columbia--(BUSINESS WIRE)--Life Sciences BC Announces Companies and Mentors for Fifth Annual Investor Readiness Program
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Natural Products Canada (NPC), the driving force behind bio-based innovation in Canada, is proud to unveil its 2024 Game Changers report.
OTTAWA, Ontario--(BUSINESS WIRE)--BioTalent Canada announced today a new project that will uncover insights and shape strategies to transform the inclusivity, diversity, equity, and accessibility (IDEA) of the workforce in Alberta’s bio-economy. This project, funded in part by the Province of Alberta in partnership with the Government of Canada, involves working alongside industry partners and collaborators to conduct a labour market study to better understand the employment rate and critical b
